Home
Home » companies

Pharmacyclics

This Just In: More Upgrades and Downgrades

This Just In: More Upgrades and Downgrades
Motley Fool

Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers

Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha

Pharmacyclics Outperformed Other Biotechs In June With A 74% Gain

Pharmacyclics Outperformed Other Biotechs In June With A 74% Gain
Forbes

Pharmacyclics Inc.: A Stock Up 400% This Year, A $4 Billion Company

Pharmacyclics Inc.: A Stock Up 400% This Year, A $4 Billion Company
Seeking Alpha

3 Rallying Drug-Makers Being Snapped Up By Insiders

3 Rallying Drug-Makers Being Snapped Up By Insiders
Seeking Alpha

Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug

Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug
Yahoo/AP

Pharmacyclics advances after reporting new data for blood cancer drug candidate ibrutinib

Pharmacyclics advances after reporting new data for blood cancer drug candidate ibrutinib
Yahoo/AP

ASCO Stocks To Consider This Week

ASCO Stocks To Consider This Week
Seeking Alpha

2 Drug Combination Stocks Targeting Leukemia

2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha

ASCO '12 Abstract Dump: Cancer Stocks in Focus

ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com